Ozempic retails for roughly $900–$1,200 per month without insurance — one of the most expensive maintenance medications in the US pharmacy market. Most patients don’t pay anywhere close to that. Here’s how Ozempic pricing actually breaks down across insurance types and discount programs in 2026.
Cash / Retail Price (No Insurance)
List prices in 2026 are typically:
- Ozempic 0.25 mg / 0.5 mg pen: ~$935/month
- Ozempic 1 mg pen: ~$935/month
- Ozempic 2 mg pen: ~$935/month
Pricing varies by pharmacy. Costco, GoodRx, and warehouse pharmacies often have lower cash prices. Manufacturer Novo Nordisk has not lowered the US list price meaningfully since launch despite multiple congressional inquiries.
With Commercial Insurance
Most commercial insurance plans cover Ozempic for FDA-approved use (type 2 diabetes) when you meet step-therapy requirements (usually: tried metformin first, A1C still >7%). Typical out-of-pocket after insurance:
- In-network preferred tier: $25 – $50/month
- In-network non-preferred tier: $50 – $200/month
- Specialty tier (rare): $100 – $500/month plus coinsurance
- High-deductible plan before meeting deductible: full retail
Novo Nordisk Savings Card
Novo Nordisk offers a savings card that can reduce out-of-pocket to $25/month for eligible commercially-insured patients. Eligibility excludes Medicare, Medicaid, VA, and other government-funded plans. Apply at ozempic.com.
Medicare Coverage
Medicare Part D plans typically cover Ozempic for type 2 diabetes. Coverage in the coverage gap (“donut hole”) can be expensive — monthly out-of-pocket may rise to $200–$500 during that phase before catastrophic coverage kicks in. Medicare does not cover Wegovy or Ozempic for weight loss only.
Medicaid Coverage
Medicaid coverage varies by state. Most state Medicaid programs cover Ozempic for type 2 diabetes after step therapy requirements.
Compounded Semaglutide: Cheaper but Risky
Compounding pharmacies have offered semaglutide for $200–$400/month during periods of branded shortage. The FDA has issued multiple warnings about safety of compounded GLP-1 products, including dosing errors, contamination, and use of non-FDA-approved salt forms (semaglutide acetate vs. the prescription-grade semaglutide sodium). Compounded semaglutide is no longer permitted under FDA shortage rules after late 2024 when the branded supply was deemed sufficient.
How to Pay the Least for Ozempic
- If commercially insured: apply the Novo Nordisk savings card on top of insurance ($25/month is typical)
- If uninsured: check the manufacturer Patient Assistance Program; check GoodRx coupons; ask your doctor for samples during titration
- If Medicare: compare Part D plans in October each year — Ozempic copays vary significantly between plans
- If your insurance won’t cover: appeal in writing with your doctor’s letter; many denials are reversed on first appeal
Sources & Further Reading
- Novo Nordisk — Ozempic Savings Card
- FDA — Compounded Semaglutide Warning
- Medicare.gov — Part D Coverage
